Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1;22(3):1459.
doi: 10.3390/ijms22031459.

Factor XIII-A in Diseases: Role Beyond Blood Coagulation

Affiliations
Review

Factor XIII-A in Diseases: Role Beyond Blood Coagulation

Katalin Dull et al. Int J Mol Sci. .

Abstract

Multidisciplinary research from the last few decades has revealed that Factor XIII subunit A (FXIII-A) is not only involved in blood coagulation, but may have roles in various diseases. Here, we aim to summarize data from studies involving patients with mutations in the F13A1 gene, performed in FXIII-A knock-out mice models, clinical and histological studies assessing correlations between diseases severity and FXIII-A levels, as well as from in vitro experiments. By providing a complex overview on its possible role in wound healing, chronic inflammatory bowel diseases, athe-rosclerosis, rheumatoid arthritis, chronic inflammatory lung diseases, chronic rhinosinusitis, solid tumors, hematological malignancies, and obesity, we also demonstrate how the field evolved from using FXIII-A as a marker to accept and understand its active role in inflammatory and malignant diseases.

Keywords: Factor XIII subunit A; chronic inflammatory diseases; malignancies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary overview of diseases discussed in this review in which FXIII-A may play a role. Created with BioRender.com.

References

    1. Muszbek L., Yee V.C., Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb. Res. 1999;94:271–305. doi: 10.1016/S0049-3848(99)00023-7. - DOI - PubMed
    1. Lorand L. Factor XIII: Structure, activation, and interactions with fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 2001;936:291–311. doi: 10.1111/j.1749-6632.2001.tb03516.x. - DOI - PubMed
    1. Lorand L. Factor XIII and the clotting of fibrinogen: From basic research to medicine. J. Thromb. Haemost. 2005;3:1337–1348. doi: 10.1111/j.1538-7836.2005.01213.x. - DOI - PubMed
    1. Ariëns R.A.S., Lai T.S., Weisel J.W., Greenberg C.S., Grant P.J. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100:743–754. doi: 10.1182/blood.V100.3.743. - DOI - PubMed
    1. Polgar J., Hidasi V., Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage Factor XIII) Biochem. J. 1990;267:557–560. doi: 10.1042/bj2670557. - DOI - PMC - PubMed

LinkOut - more resources